Response Genetics, Inc. filed a voluntary petition for reorganization under Chapter 11 in the US Bankruptcy Court for the District of Delaware on August 9, 2015. The debtor listed its assets of $15.41 million and liabilities $16.16 million. The largest unsecured creditors include Life Technologies Corporation, Abbott Molecular Inc., The Trout Group LLC, Affymetrix Inc., University of Southern California, Willkie Farr & Gallagher LLP, XIFIN, Inc., Blue Cross of California, Inc., Flatiron Capital Corp.

and Hogan Lovells US LLP. The debtor is represented by James E. O'Neill of Pachulski Stang Ziehl &Jones LLP as its legal counsel and Canaccord Genuity, Inc. as its Investment Banker. The debtor also hired Benjamin J. Matz of MacKenzie, Inc. as chief restructuring officer and Omni Management Group, LLC as Claims & Noticing Agent.